Implications of PPPDE1 expression in the distribution of plakoglobin and β‑catenin in pancreatic ductal adenocarcinoma

Kang,Yu‑Huan; Shen,Cong‑Cong; Yao,Yu-Qin; Yu,Lin; Cui,Xin‑Yi; He,Yi; Yang,Jin‑Liang; Gou,Lan‑Tu

doi:10.3892/ol.2014.2279

Implications of PPPDE1 expression in the distribution of plakoglobin and β‑catenin in pancreatic ductal adenocarcinoma

Authors:
- Yu‑Huan Kang
- Cong‑Cong Shen
- Yu-Qin Yao
- Lin Yu
- Xin‑Yi Cui
- Yi He
- Jin‑Liang Yang
- Lan‑Tu Gou
View Affiliations

Affiliations: State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Department of Medical Oncology, The Fifth People's Hospital of Chengdu, Chengdu, Sichuan 611130, P.R. China
Published online on: June 24, 2014 https://doi.org/10.3892/ol.2014.2279
Pages: 1229-1233

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Human PPPDE peptidase domain‑containing protein 1 (PPPDE1) is a recently identified protein; however, its exact functions remain unclear. In our previous study, the PPPDE1 protein was found to be decreased in certain cancer tissues. In the present study, a total of 96 pancreatic ductal carcinoma tissue samples and 31 normal tissues samples were assessed to investigate the distribution of plakoglobin and β‑catenin under the conditions of various PPPDE1 expression levels by means of immunohistochemistry. Generally, the staining of PPPDE1 was strong in normal tissues, but weak in cancer tissues. Plakoglobin was mainly distributed along the membrane and cytoplasm border in normal cells, but was less evident in the membranes of cancer cells. In particular, a greater percentage of cells exhibited low membrane plakoglobin expression in cancer tissue with low PPPDE1 expression (PPPDE1‑low cancer) compared with that in cancer tissue with high PPPDE1 expression (PPPDE1‑high cancer). The distribution of β‑catenin in normal tissues was similar to that of plakoglobin. However, β‑catenin was peculiarly prone to invade nucleus in PPPDE1‑low cancer compared with PPPDE1‑high cancer. Our data suggested potential links between PPPDE1 expression and the distribution of plakoglobin and β‑catenin in pancreatic ductal adenocarcinoma, providing insights into the role of PPPDE1 in the progression of pancreatic cancer.

View Figures

View References

1	Gregory SG, Barlow KF, McLay KE, et al: The DNA sequence and biological annotation of human chromosome 1. Nature. 441:315–321. 2006.
2	Lai CH, Chou CY, Ch’ang LY, Liu CS and Lin W: Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics. Genome Res. 10:703–713. 2000.
3	Iyer LM, Koonin EV and Aravind L: Novel predicted peptidases with a potential role in the ubiquitin signaling pathway. Cell Cycle. 3:1440–1450. 2004.
4	Yan F, Gou L, Yang J, et al: A novel pro-apoptosis gene PNAS4 that induces apoptosis in A549 human lung adenocarcinoma cells and inhibits tumor growth in mice. Biochimie. 91:502–507. 2009.
5	Yao S, Xie L, Qian M, et al: Pnas4 is a novel regulator for convergence and extension during vertebrate gastrulation. FEBS Lett. 582:2325–2332. 2008.
6	Yan F, Ruan XZ, Yang HS, et al: Identification, characterization, and effects of Xenopus laevis PNAS-4 gene on embryonic development. J Biomed Biotechnol. 2010:1347642010.
7	He Y, Wang J, Gou L, et al: Comprehensive analysis of expression profile reveals the ubiquitous distribution of PPPDE peptidase domain 1, a Golgi apparatus component, and its implications in clinical cancer. Biochimie. 95:1466–1475. 2013.
8	Zhu M, Xu Z, Wang K, Wang N and Li Y: microRNA and gene networks in human pancreatic cancer. Oncol Lett. 6:1133–1139. 2013.
9	Morris JP IV, Cano DA, Sekine S, Wang SC and Hebrok M: Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J Clin Invest. 120:508–520. 2010.
10	Kobayashi T, Shimura T, Yajima T, et al: Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin. Int J Cancer. 129:2775–2786. 2011.
11	Clevers H and Nusse R: Wnt/β-catenin signaling and disease. Cell. 149:1192–1205. 2012.
12	Noubissi FK, Elcheva I, Bhatia N, et al: CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling. Nature. 441:898–901. 2006.
13	Aktary Z and Pasdar M: Plakoglobin: role in tumorigenesis and metastasis. Int J Cell Biol. 2012:1895212012.
14	Zhurinsky J, Shtutman M and Ben-Ze’ev A: Plakoglobin and beta-catenin: protein interactions, regulation and biological roles. J Cell Sci. 113(Pt 18): 3127–3139. 2000.
15	Gou L, Wang W, Tong A, et al: Proteomic identification of RhoA as a potential biomarker for proliferation and metastasis in hepatocellular carcinoma. J Mol Med (Berl). 89:817–827. 2011.
16	Shin EJ, Shin HM, Nam E, et al: DeSUMOylating isopeptidase: a second class of SUMO protease. EMBO Rep. 13:339–346. 2012.
17	Wang Y and Dasso M: SUMOylation and deSUMOylation at a glance. J Cell Sci. 122(Pt 23): 4249–4252. 2009.
18	Gou LT, Tong AP, Yan F, et al: Altered protein-expressing profile in hPNAS4-induced apoptosis in A549 human lung adenocarcinoma cells. J Cell Biochem. 108:1211–1219. 2009.
19	Dusek RL and Attardi LD: Desmosomes: new perpetrators in tumour suppression. Nat Rev Cancer. 11:317–323. 2011.
20	Wei Q, Hariharan V and Huang H: Cell-cell contact preserves cell viability via plakoglobin. PLoS One. 6:e270642011.
21	Bailey CK, Mittal MK, Misra S and Chaudhuri G: High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG. J Biol Chem. 287:19472–19486. 2012.
22	Yin T, Getsios S, Caldelari R, et al: Mechanisms of plakoglobin-dependent adhesion: desmosome-specific functions in assembly and regulation by epidermal growth factor receptor. J Biol Chem. 280:40355–40363. 2005.
23	Maeda O, Usami N, Kondo M, et al: Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line. Oncogene. 23:964–972. 2004.
24	Gavert N and Ben-Ze’ev A: beta-Catenin signaling in biological control and cancer. J Cell Biochem. 102:820–828. 2007.
25	Choi HJ, Gross JC, Pokutta S and Weis WI: Interactions of plakoglobin and beta-catenin with desmosomal cadherins: basis of selective exclusion of alpha- and beta-catenin from desmosomes. J Biol Chem. 284:31776–31788. 2009.
26	Solanas G, Miravet S, Casagolda D, et al: beta-Catenin and plakoglobin N- and C-tails determine ligand specificity. J Biol Chem. 279:49849–49856. 2004.